Antibiotic treatment and factors influencing short and long term outcomes of acute exacerbations of chronic bronchitis

Por Wilson, R, Jones, P, Schaberg, T, Arvis, P, Duprat‐Lomon, I, Sagnier, P P
Publicado em 2006

Determinants of bacteriological outcomes in exacerbations of chronic obstructive pulmonary disease

Por Sethi, S., Anzueto, A., Miravitlles, M., Arvis, P., Alder, J., Haverstock, D., Trajanovic, M., Wilson, R.
Publicado no Infection (2015)

Efficacy and safety of IV/PO moxifloxacin and IV piperacillin/tazobactam followed by PO amoxicillin/clavulanic acid in the treatment of diabetic foot infections: results of the REL...

Por Schaper, N. C., Dryden, M., Kujath, P., Nathwani, D., Arvis, P., Reimnitz, P., Alder, J., Gyssens, I. C.
Publicado em 2012

Moxifloxacin versus ofloxacin plus metronidazole in uncomplicated pelvic inflammatory disease: results of a multicentre, double blind, randomised trial

Por Ross, J D C, Cronjé, H S, Paszkowski, T, Rakoczi, I, Vildaite, D, Kureishi, A, Alefelder, M, Arvis, P, Reimnitz, P
Publicado em 2006